Trials / Terminated
TerminatedNCT03184415
Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis
A Multi-Center, Randomized, Parallel, Double-Blind, Phase III Clinical Trial to Compare the Efficacy and Safety of DWC20155/DWC20156 Combination Therapy With DWC20155 or DWC20156 Monotherapy in Patients With Gastritis
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 230 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
THe purpose of this study is to evaludate the Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients with Gastritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWC20155 | tablet |
| DRUG | DWC20156 | tablet |
| DRUG | placebo of DWC20155 | tablet |
| DRUG | placebo of DWC20156 | tablet |
Timeline
- Start date
- 2017-07-03
- Primary completion
- 2018-05-17
- Completion
- 2018-05-17
- First posted
- 2017-06-12
- Last updated
- 2019-06-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03184415. Inclusion in this directory is not an endorsement.